AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Godalming, UK-based Sinclair Pharma has licensed the exclusive US rights on its seborrheic dermatitis product Sebclair to the US unit of Indian drug major Dr Reddy's. The latter will market the product under a new brand name through its new dermatology division. The agreement grants Dr Reddy's exclusivity in the USA for Sebclair and ...